途深智合 (Toursyn)

Founded in 2023 and headquartered in Wuxi, Toursynbio is an AI-native biopharmaceutical company building an autonomous AI biopharma foundry around ToursynClaw, its one-stop AI drug-design platform that pairs proprietary protein-generation and optimization models with automated wet-lab validation in a design-experiment-feedback-redesign loop. The platform targets hard-to-drug targets such as GPCRs and intrinsically disordered protein regions, as well as complex molecule types including antibodies and cyclic peptides. The company reports validating AI designs in real experiments across more than 100 antibody engineering projects, completing a design-to-validation cycle in 14 days and accumulating over 5,000 experimental data points.

  • Seed
  • AI/ML
  • Biotechnology
  • Pharmaceuticals
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 8, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 8, 2026

    Seed

    Led by Shanghai Kechuang Group (上海科创集团)

    • Shanghai Kechuang Group (上海科创集团)
    • Zero2IPO Holdings (清科控股)
    • Jinding Capital (金鼎资本)
    • MegaRobo Technologies (镁伽科技)
    • 中生引领
    • 舟山途毅

    Article coming soon.

Pricing

Research 途深智合 (Toursyn) — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if 途深智合 (Toursyn) is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational